| Literature DB >> 27471464 |
Daniela Impellizzeri1, Marika Cordaro1, Michela Campolo1, Enrico Gugliandolo1, Emanuela Esposito1, Filippo Benedetto2, Salvatore Cuzzocrea3, Michele Navarra1.
Abstract
The flavonoid-rich fraction of bergamot juice (BJe) has demonstrated anti-inflammatory and antioxidant activities. The aim of work was to test the beneficial effects of BJe on the modulation of the ileum inflammation caused by intestinal ischemia/reperfusion (I/R) injury in mice. To understand the cellular mechanisms by which BJe may decrease the development of intestinal I/R injury, we have evaluated the activation of signaling transduction pathways that can be induced by reactive oxygen species production. Superior mesenteric artery and celiac trunk were occluded for 30 min and reperfused for 1 h. The animals were sacrificed after 1 h of reperfusion, for both histological and molecular examinations of the ileum tissue. The experimental results demonstrated that BJe was able to reduce histological damage, cytokines production, adhesion molecules expression, neutrophil infiltration and oxidative stress by a mechanism involved both NF-κB and MAP kinases pathways. This study indicates that BJe could represent a new treatment against inflammatory events of intestinal I/R injury.Entities:
Keywords: Citrus bergamia; bergamot juice; cytokines; inflammation; ischemia; oxidative stress
Year: 2016 PMID: 27471464 PMCID: PMC4945634 DOI: 10.3389/fphar.2016.00203
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810